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delivery-related, and postpartum health care) and ectopic pregnancy were based on published studies. Details of the patterns of resource consumption were not reported. All costs were in US dollars ($) and were discounted at an annual rate of 3%. The price year was 2007.
Analysis of uncertainty:
One-and two-way sensitivity analyses were carried out to investigate the uncertainty surrounding most of the model inputs. The sources of the ranges used were not reported, but they were likely to have been based on published studies.
Results
Over five years, the total costs were $647 with copper-T IUD; $713 with vasectomy; $930 with levonorgestrel IUS; $1,575 with male condom; $1,597 with implant; $1,892 with FAB methods; $2,017 with withdrawals; $2,171 with diaphragm; $2,647 with spermicides; $2,676 with female condom; $2,681 with injectable contraceptives; $2,798 with sponge; $2,978 with tubal ligation; $3,158 with vaginal ring; $3,381 with oral contraceptive; $3,458 with transdermal patch; and $4,739 with no method.
The average annual percentage who did not become pregnant was 99.6% with copper-T IUD; 100% with vasectomy; 99.8% with levonorgestrel IUS; 86.6% with male condom; 100% with implant; 79.2% with FAB methods; 77.8% with withdrawals; 85.8% with diaphragm; 76.6% with spermicides; 76.8% with female condom; 97% with injectable contraceptives; 79.8% with sponge; 99.8% with tubal ligation; 92.4% with vaginal ring; 92.4% with oral contraceptive; 92.4% with transdermal patch; and 48% with no method.
Thus, all the contraceptive strategies were more effective and less costly than no method, which was always dominated.
After excluding dominated strategies, Copper-T IUD was the reference strategy and the incremental cost-effectiveness ratio was $164 with vasectomy, $1,415 with levonorgestrel IUS (over vasectomy), and $2,375 with implant (over levonorgestrel IUS).
These results were sensitive to several model inputs including the method costs, the cost of unintended pregnancy, and the time horizon. This was mainly due to the very similar effectiveness results for some contraceptive strategies. In all scenarios, the long-term contraceptives (e.g. Copper-T IUD, vasectomy, levonorgestrel IUS, and implant) were the most cost-effective and only their ranking varied.
